Claps Aldana, Kolomenski Jorge E, Fernández Franco, Macchiaroli Natalia, Ingravidi Marina L, Delea Marisol, Fernández Cecilia, Castro Tania, Laiseca Julieta, Kamenetzky Laura, Taboas Melisa, Dain Liliana
Centro Nacional de Genética Médica, Administración Nacional de Laboratorios e Institutos de Salud (ANLIS) "Dr. Carlos G Malbrán", Buenos Aires, Argentina.
Instituto de Biociencias, Biotecnología y Biología Traslacional (iB3), Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina.
Sci Rep. 2025 Jul 10;15(1):24983. doi: 10.1038/s41598-025-03799-7.
The CYP21A2 gene, mapped to the RCCX module in 6p21.3, is responsible for 21-hydroxylase deficiency (21-HD). In this work, we leveraged Oxford Nanopore Technology (ONT) Long Read sequencing (LRS) to analyze samples from an Argentinian cohort of 21-HD. A total of 34 samples were sequenced in 2 amplicons of 8.5 Kb covering the centromeric and telomeric RCCX modules. The number of variants found varied between 3 and 106 and all expected pathogenic variants and new ones were obtained with the LR sequencing workflow developed. We defined with higher accuracy the breakpoints of the rearrangements allowing the reclassification of chimeras and/or converted genes in 18.75% of the samples, some of them with clinical implications. By addressing the study of the telomeric RCCX module/s in depth, we found 19 genetic variants (GVs) for CYP21A1P and 29 GVs for TNXA not previously described in Latin American populations. This study may represent the first application of ONT LRS for clinical evaluation of Latin American subjects, highlighting the importance of LRS as a high-resolution method of diagnosis. It would allow a better understanding of the diversity of the RCCX modules and improve our knowledge of the variation of genetic mechanisms behind the disease.
CYP21A2基因定位于6p21.3的RCCX模块,与21 - 羟化酶缺乏症(21 - HD)相关。在本研究中,我们利用牛津纳米孔技术(ONT)长读长测序(LRS)对来自阿根廷一个21 - HD队列的样本进行分析。共对34个样本进行测序,测序区域为覆盖着丝粒和端粒RCCX模块的2个8.5 Kb扩增子。发现的变异数量在3至106个之间,并且通过所开发的长读长测序流程获得了所有预期的致病变异和新变异。我们更准确地确定了重排的断点,使18.75%的样本中的嵌合体和/或转化基因得以重新分类,其中一些具有临床意义。通过深入研究端粒RCCX模块,我们发现了19个CYP21A1P基因变异(GVs)和29个TNXA基因变异,这些变异在拉丁美洲人群中此前未曾描述过。本研究可能代表了ONT LRS在拉丁美洲受试者临床评估中的首次应用,突出了LRS作为一种高分辨率诊断方法的重要性。它将有助于更好地理解RCCX模块的多样性,并增进我们对该疾病背后遗传机制变异的认识。